The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
Traditional Chinese medicine reimbursement reform in China: implementation progress, policy constraints, and optimization strategies. [PDF]
Zhao F, Chen Y, Tong X.
europepmc +1 more source
Diaspora-driven knowledge diplomacy: rethinking transnational education through the CIESDEMEX model in the Global South. [PDF]
Romero León DA +2 more
europepmc +1 more source
Making Home-Based End-of-Life Care a Realistic Choice: A Narrative Review of Linkages Between Community Care and Specialized Hospice Institutions in South Korea. [PDF]
Kwon SH.
europepmc +1 more source
How do academic institutions assess and demonstrate their social mission? A scoping review protocol. [PDF]
Oubouchou R +8 more
europepmc +1 more source
Operationalising the ESSENCE principles for equitable global health research partnerships in low- and middle-income countries: lessons from the RESPIRE collaboration. [PDF]
Salim H +5 more
europepmc +1 more source
From equity to solidarity: how care and relationality transform the debate on justice in genomics. [PDF]
Prainsack B.
europepmc +1 more source

